Ellipse Technologies, Inc.
7
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Computerized Tomography (CT) Scan Study of Bone Healing Following Open Wedge Proximal Tibial Osteotomy
Role: lead
Post-Market Study of the Ellipse PRECICE Intramedullary Limb Lengthening System
Role: lead
Treatment of Adolescent Idiopathic Scoliosis Patients Using the Ellipse MAGEC System
Role: lead
Ellipse Intramedullary High Tibial Osteotomy Nail Study
Role: lead
Study of the Surgical Treatment of Early Onset Scoliosis Using a Non-invasive Growing Rod
Role: lead
Ellipse Intramedullary Nail High Tibial Osteotomy Study
Role: lead
A Retrospective Review of Early Onset Spinal Deformity Patients Treated With the Ellipse MAGEC System
Role: lead
All 7 trials loaded